Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
294,683,714
-
Total 13F shares
-
48,883,624
-
Share change
-
-879,340
-
Total reported value
-
$746,320,055
-
Put/Call ratio
-
3.3%
-
Price per share
-
$15.27
-
Number of holders
-
154
-
Value change
-
-$18,445,491
-
Number of buys
-
84
-
Number of sells
-
58
Institutional Holders of SANGAMO THERAPEUTICS, INC - Common Stock (SGMO) as of Q2 2014
As of 30 Jun 2014,
SANGAMO THERAPEUTICS, INC - Common Stock (SGMO) was held by
154 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
48,883,624 shares.
The largest 10 holders included
FMR LLC, WASATCH ADVISORS INC, RA CAPITAL MANAGEMENT, LLC, ADAGE CAPITAL PARTNERS GP LLC, BlackRock Fund Advisors, FRONTIER CAPITAL MANAGEMENT CO LLC, State Street Corp, VANGUARD GROUP INC, BlackRock Institutional Trust Company, N.A., and JENNISON ASSOCIATES LLC.
This page lists
154
institutional shareholders reporting positions in this security
for the Q2 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.